MEM 16.7% 0.5¢ memphasys limited.

Ann: FELIX product development and commercialisation update, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 108 Posts.
    lightbulb Created with Sketch. 74
    I'm not sure if there is any reason to buy this stock until at least half way through 2020.  The product is all but finished and will soon be undergoing trials by key opinion leaders.  After that we need to wait for certification and then commercialisation.  It doesn't seem like there will be any left-field announcements except possibly of the negative kind, i.e. running out of money (I'm not saying that is likely).  I'm sure that Memphasys is already confident of the outcome of the trials as they would have done extensive testing themselves.  Can anyone think of a reason to jump in now with such a long and seemingly uneventful wait until commercialisation?  There just doesn't seem to be any catalyst for the price to go up until then.
 
watchlist Created with Sketch. Add MEM (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $13.00M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $19.10K 3.821M

Buyers (Bids)

No. Vol. Price($)
11 4204169 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 5374720 3
View Market Depth
Last trade - 15.56pm 07/11/2024 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.